Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • reema
    Member
    • Feb 2014
    • 27

    #1

    CEGMA complete/partial depend on number of sequences?

    Hello Everybody

    I have a question related to CEGMA complete and partial score . We have done the assembly by Trinity and then assembled trinity transcripts in more complete transcript set. Now when we find out the number of complete and partial CEGMA score, that makes us a bit confuse. Here's the description:-

    Trinity Transcripts [A] [Total 31259] = 202 complete, 229 partial
    Assembled Trinity Transcripts [B] [Total 19920]= 186 complete, 213 partial

    As the set B has more completed transcript, we are expecting high score for complete and partial as compare to set A [ where the transcripts are fragmented]. We are doubting that this difference in score is because of the total number of transcripts. Set B has lower number of transcripts as compare to set A so set B has lower CEGMA score as compare to Set!. But we are not sure. So my question is :-

    1) Is Cegma Complete and partial score also depend on the total number of transcripts/sequences?

    Any suggestion would be very helpful.

    Many Thanks,
    Reema,
  • kbradnam
    Member
    • May 2011
    • 54

    #2
    CEGMA does not care about the number of sequences in your input assembly. CEGMA was designed to work against genome, not transcriptome, assemblies; so you could have just one (very long) sequence in your input and still have 248 complete genes present.

    The most parsimonious explanation —*to me anyway*— of your results is that your dataset B contains many incorrectly assembled transcripts compared to dataset A, such that CEGMA can not map as many complete (or partial) genes to the sequences. You could identify the complete genes that are in A and not B, and then BLAST them against B to see if they exist in any form (maybe as strange chimeric transcripts?).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...